Free Trial Information
BioCentury | Nov 16, 2019
Company News

Management tracks: Lonza CEO to step down; plus Arrowhead, Insmed, Inozyme, Yukin, Pfenex, EyePoint, Verseau, Abingworth, CBC, Flagship, Diverse, Theragnostics,

...which focuses on rare mineralization disorders, hired Pedro Huertas as CMO. He was CMO at Sentien Biotechnologies Inc....
Read More
BioCentury | Oct 2, 2018
Company News

Management tracks: Synlogic, Trevena, Editas

...responsibility at the Novartis Group (China) unit of Novartis AG (NYSE:NVS; SIX:NOVN). Cell therapy company Sentien Biotechnologies Inc....
Read More
BioCentury | Apr 14, 2017
Financial News

Sentien completes venture financing

...On April 4, cell therapy company Sentien Biotechnologies Inc. (Cambridge, Mass.) raised $12 million in a series A...
...Ventures, MBL Venture Capital and Mass Medical Angels also participated. Sentien Biotechnologies Inc. , Cambridge, Mass. Jaime De Leon Sentien Biotechnologies Inc....
Read More
BioCentury | Aug 17, 2015
Financial News

Sentien Biotechnologies completes venture financing

Sentien Biotechnologies Inc. , Medford, Mass. Business: Renal Date completed: 2015-08-07 Type: Venture financing Raised: Not disclosed Investors: Boehringer Ingelheim Venture Fund; Portage Biotech Note: The amount raised is not disclosed. WIR Staff Renal...
Read More
Items per page:
1 - 4 of 4
BioCentury | Nov 16, 2019
Company News

Management tracks: Lonza CEO to step down; plus Arrowhead, Insmed, Inozyme, Yukin, Pfenex, EyePoint, Verseau, Abingworth, CBC, Flagship, Diverse, Theragnostics,

...which focuses on rare mineralization disorders, hired Pedro Huertas as CMO. He was CMO at Sentien Biotechnologies Inc....
Read More
BioCentury | Oct 2, 2018
Company News

Management tracks: Synlogic, Trevena, Editas

...responsibility at the Novartis Group (China) unit of Novartis AG (NYSE:NVS; SIX:NOVN). Cell therapy company Sentien Biotechnologies Inc....
Read More
BioCentury | Apr 14, 2017
Financial News

Sentien completes venture financing

...On April 4, cell therapy company Sentien Biotechnologies Inc. (Cambridge, Mass.) raised $12 million in a series A...
...Ventures, MBL Venture Capital and Mass Medical Angels also participated. Sentien Biotechnologies Inc. , Cambridge, Mass. Jaime De Leon Sentien Biotechnologies Inc....
Read More
BioCentury | Aug 17, 2015
Financial News

Sentien Biotechnologies completes venture financing

Sentien Biotechnologies Inc. , Medford, Mass. Business: Renal Date completed: 2015-08-07 Type: Venture financing Raised: Not disclosed Investors: Boehringer Ingelheim Venture Fund; Portage Biotech Note: The amount raised is not disclosed. WIR Staff Renal...
Read More
Items per page:
1 - 4 of 4